Hubei, China

Bifeng Liu

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 9.4

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Wuhan, CN (2015 - 2016)
  • Hubei, CN (2015 - 2019)

Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Bifeng Liu: Innovator in Pharmaceutical Chemistry

Introduction

Bifeng Liu is a notable inventor based in Hubei, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address neuropsychiatric diseases. With a total of 4 patents to his name, Liu's work is recognized for its potential impact on medical treatments.

Latest Patents

Liu's latest patents include a fused heterocyclic compound derivative and its application. This invention relates specifically to pharmaceutical chemistry and offers a structure that can be utilized in treating neuropsychiatric diseases. Another significant patent is for a benzopyrone derivative, which also addresses neuropsychical diseases. This compound, or its pharmaceutically acceptable salt, has shown promise in both prevention and treatment through experimental findings.

Career Highlights

Throughout his career, Bifeng Liu has worked with prominent organizations, including Nhwa Pharmaceutical Corporation and Huazhong University of Science and Technology. His experience in these institutions has allowed him to advance his research and contribute to the pharmaceutical field effectively.

Collaborations

Liu has collaborated with notable colleagues such as Guisen Zhang and Yin Chen. These partnerships have likely enhanced his research capabilities and broadened the scope of his inventions.

Conclusion

Bifeng Liu's innovative work in pharmaceutical chemistry demonstrates his commitment to addressing critical health issues through his inventions. His contributions are paving the way for advancements in the treatment of neuropsychiatric diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…